ACAD
Acadia Pharmaceuticals Inc. · Healthcare
EVP and CFO Mark C. Schneyer sold $35K of Acadia Pharmaceuticals Inc.
Sold$34,795
$18.16Price
1,916Shares
−20%Stake
What ACAD did after the filing
- The stock from Mon, Apr 10 open, $18.14
- +36.7%
- S&P 500, same days
- +3.0%
Measured over 30 trading days, to the May 22 close.
Traded Thu, Apr 6. Filed Fri, Apr 7, 8:37 PM ET, after the close. Returns use the Apr 10 open and the May 22 close. Not investment advice.